These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 20095375)

  • 1. [Interferon alpha-2b in the complex therapy of patients with pulmonary tuberculosis concurrent with bronchoobstructive syndrome].
    Zhukova EM; Krasnov VA; Petrenko TI; Romanov VV
    Tuberk Biolezni Legkih; 2009; (12):58-61. PubMed ID: 20095375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinoma.
    Tannir NM; Cohen L; Wang X; Thall P; Mathew PF; Jonasch E; Siefker-Radtke A; Pagliaro LC; Ng CS; Logothetis C
    Cancer; 2006 Nov; 107(9):2254-61. PubMed ID: 17029276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vivo and vitro effects of interferon-alpha 2b on functional activity of T-lymphocytes from patients with rheumatoid arthritis].
    Iarilina AA; Nikonova MF; Litvina MM; Balabanova RM; Iarilin AA
    Ter Arkh; 2000; 72(5):9-17. PubMed ID: 11109610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of using external laser irradiation in the complex treatment of patients with pulmonary tuberculosis with concomitant bronchial obstruction syndrome].
    Khomenko AG; Omarov TO; Kaminskaia GO; Blonskaia GIu
    Probl Tuberk; 1991; (8):32-6. PubMed ID: 1758854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.
    Saruc M; Ozden N; Turkel N; Ayhan S; Hock LM; Tuzcuoglu I; Yuceyar H
    J Pharm Sci; 2003 Jul; 92(7):1386-95. PubMed ID: 12820143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma.
    Lümmen G; Goepel M; Möllhoff S; Hinke A; Otto T; Rübben H
    J Urol; 1996 Feb; 155(2):455-8. PubMed ID: 8558634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with interferon-alpha-2b in children with life-threatening hemangiomas.
    Jiménez-Hernández E; Dueñas-González MT; Quintero-Curiel JL; Velásquez-Ortega J; Magaña-Pérez JA; Berges-García A; Arellano-Galindo J
    Dermatol Surg; 2008 May; 34(5):640-7. PubMed ID: 18261103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effect of recombinant interferon alpha-2b on hemorrhagic fever with renal syndrome].
    Fu C; Jia H; Gong M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Dec; 12(4):370-2. PubMed ID: 12526358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of hepatitis B vaccination and interferon-alpha-2b combination therapy versus interferon-alpha-2b monotherapy in children with chronic hepatitis B.
    Helvaci M; Kizilgunesler A; Kasirga E; Ozbal E; Kuzu M; Sozen G
    J Gastroenterol Hepatol; 2004 Jul; 19(7):785-91. PubMed ID: 15209626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of recombinant human interferon alpha-2b on experimental endometriosis.
    Altintas D; Kokcu A; Tosun M; Cetinkaya MB; Kandemir B
    Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):95-9. PubMed ID: 17961906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar effects of recombinant interferon-alpha-2b and natural interferon-alpha when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma.
    Uka K; Aikata H; Takaki S; Miki D; Jeong SC; Hiramatsu A; Kodama H; Shirakawa H; Kawakami Y; Takahashi S; Toyota N; Ito K; Chayama K
    Liver Int; 2007 Nov; 27(9):1209-16. PubMed ID: 17919232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional recombinant interferon alpha-2b in Peyronie's disease.
    Astorga R; Cantero O; Contreras D; del Río-Martín A; Labarta-Beceiro V; Gutiérrez-Elvírez A; Lima-López MA; López-Saura P
    Arch Esp Urol; 2000 Sep; 53(7):665-71. PubMed ID: 11037665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant interferon alpha-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: a 3-year trial with recombinant interferon-alpha and 5-year follow-up.
    Rusciani L; Proietti I; Paradisi A; Rusciani A; Guerriero G; Mammone A; De Gaetano A; Lippa S
    Melanoma Res; 2007 Jun; 17(3):177-83. PubMed ID: 17505263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991).
    Eggermont AM; Bouwhuis MG; Kruit WH; Testori A; ten Hagen T; Yver A; Xu C
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):671-7. PubMed ID: 19621225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition.
    Lara PN; Quinn DI; Margolin K; Meyers FJ; Longmate J; Frankel P; Mack PC; Turrell C; Valk P; Rao J; Buckley P; Wun T; Gosselin R; Galvin I; Gumerlock PH; Lenz HJ; Doroshow JH; Gandara DR;
    Clin Cancer Res; 2003 Oct; 9(13):4772-81. PubMed ID: 14581348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4.
    Alfaleh FZ; Hadad Q; Khuroo MS; Aljumah A; Algamedi A; Alashgar H; Al-Ahdal MN; Mayet I; Khan MQ; Kessie G
    Liver Int; 2004 Dec; 24(6):568-74. PubMed ID: 15566506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.
    Giosuè S; Casarini M; Ameglio F; Zangrilli P; Palla M; Altieri AM; Bisetti A
    Eur Cytokine Netw; 2000 Mar; 11(1):99-104. PubMed ID: 10705306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peg-interferon alpha-2a versus Peg-interferon alpha-2b in nonresponders with HCV active chronic hepatitis: a pilot study.
    Scotto G; Fazio V; Fornabaio C; Tartaglia A; Di Tullio R; Saracino A; Angarano G
    J Interferon Cytokine Res; 2008 Oct; 28(10):623-9. PubMed ID: 18778199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durability of serological remission in chronic hepatitis C treated with interferon-alpha-2B.
    Sim H; Yim C; Krajden M; Heathcote J
    Am J Gastroenterol; 1998 Jan; 93(1):39-43. PubMed ID: 9448171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.